Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results
Kronos Bio, Inc. (Nasdaq: KRON), a biopharmaceutical company, today reported fourth quarter and full year 2024 financial ...
Morningstar3d
Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results
SAN MATEO, Calif., and CAMBRIDGE, Mass., March 18, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a biopharmaceutical company, today reported fourth ...